683 related articles for article (PubMed ID: 11441119)
1. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
3. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
5. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
6. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
8. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
11. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
13. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
14. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
[TBL] [Abstract][Full Text] [Related]
15. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
Hill NJ; Van Gunst K; Sarvetnick N
J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
[TBL] [Abstract][Full Text] [Related]
16. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
19. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
